Susan G. Komen for the Cure® Research Programs plays a critical role in energizing science to find the cures by funding the discoveries, individuals, and resources essential to ending breast cancer. The Programs support research and training through many different types of grants and awards, each designed to meet specific objectives and to optimize outcomes toward reducing breast cancer incidence and mortality within the decade.
As the global leader in the fight against breast cancer, we strive to identify the best science around the world. We are proud to currently fund research in 9 countries. Applications are welcome from investigators anywhere across the globe.
Funding Opportunities
(Please Read)
FY2012-13 Requests for Applications: To be issued in Fall 2012.
FY2011-12 Requests for Applications: Applications are no longer being accepted
Decision date – April 30, 2012. For funded applications, Grant terms are expected to initiate in Spring 2012.
See below for information about RFAs issued for the FY2011-2012 fiscal year.
Research Grants
Promise Grants
$7.5 million combined direct and indirect costs over 5 years
Scientific Focus: The causes of and/or approaches to the study of late recurrence, which is defined as breast cancer recurrence occurring more than five years after the original diagnosis.
Objective: Promise Grants seek to support integrated programs of collaborative and cross-disciplinary research projects leading to the accelerated translation of scientific discoveries into intervenions and strategies having the greatest potential to significantly reduce breast cancer incidence and mortality.
RFA Released: June 16, 2011
Application system open date: June 22, 2011
Pre-Application Submission deadline: August 1, 2011
Investigator- Initiated Research (IIR)
$1,000,000 combined direct and indirect costs
($250,000 per year for up to 4 years)
Eligibility:
PIs, Co-PIs, and institutions must conform to the following eligibility criteria to be considered for funding through an IIR Grant. Eligibility requirements must be met at the time of full application submission.
PIs and Co-PIs
• Must have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent
• Must not simultaneously apply for a Komen Career Catalyst Research Grant or be the Principal Investigator (PI) on a Career Catalyst Research Grant currently in the first or second year of funding
• Must ensure that all past and current Komen-funded Grants are up to date and in compliance with all Komen requirements; e.g., progress report submissions, IRB approvals, etc.
• Are not required to be U.S. citizens or residents.
Institutions
• Primary institution must be a nonprofit institution or organization anywhere in the world
• Other participating institutions may be nonprofit institutions or industry partners, however, industry partners may not be reimbursed for any fee or profit • All institutions and industry partners must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants including, for example, regulatory assurances, ownership of equipment, intellectual property, liability and insurance and reporting requirements.
Scientific Focus:
Prevention/Early Detection: Premalignant Lesions (including atypical hyperplasia and carcinoma in situ)
Novel Therapeutics and/or Resistance: Targeted Therapies for Triple Negative Breast Cancer
Biology of Breast Cancer: Host and/or Tumor Genetics
Disparities in Breast Cancer Outcomes Across Population Groups
Objective: IIR Grants seek to stimulate exploration of new ideas and novel approaches in breast cancer research and clinical practice that have the potential to lead to reductions in breast cancer incidence and mortality within the next decade.
RFA Released: June 27, 2011
Application system open date: July 1, 2011
Pre-Application Submission deadline: August 15, 2011
Career Catalyst Research (CCR)
$450,000 combined direct and indirect costs
($150,000 per year for up to 3 years)
Eligibility:
Applicants and institutions must conform to the following eligibility criteria to apply for a CCR Grant. Eligibility requirements must be met at the time of full application submission.
Applicants
• Must have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent
• Must currently hold a faculty appointment
• Must not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 6 years at the time of application
• Must not currently hold or simultaneously apply for a Komen Investigator-Initiated Research Grant
• Must not currently be a Principal Investigator or Co-Principal Investigator on an existing R01-type research grant from any national funding organization, excluding training grants such as a postdoctoral fellowship or NCI K award
• Bench scientists must have adequate space to conduct proposed research
• Must ensure that all past and current Komen-funded grants are up to date and in compliance with all Komen requirements; e.g., progress report submissions, IRB approvals, etc.
• Are not required to be U.S. citizens or residents
Institutions
• Must be a nonprofit institution or organization anywhere in the world
Research Areas:
Basic: To expand skills and expertise in basic sciences and methods substantially advancing progress in breast cancer research and have significant potential to lead to future reductions in breast cancer incidence and/or mortality.
Translational/Clinical: To expand skill and expertise in the application of laboratory, clinical and applied disciplines to research translating laboratory, clinical and/or population discoveries into important new clinical tools and applications, with significant potential to reduce breast cancer incidence and/or mortality within the decade.
Disparities in Breast Cancer Outcomes across Population Groups: To expand understanding of the biologic, behavioral and social causes of disparities in breast cancer outcomes across population groups. Or expanding expertise in identifying, validating and testing health services and public health interventions that address the causes of disparities in care and outcomes across population groups.
Objective: CCR Grants provide unique opportunities for scientists in the early stages of their careers to achieve research independence.
RFA Release Date: July 1, 2011
Application system open date: July 14, 2011
Pre-Application Submission deadline: August 30, 2011
Fellowships and Training Grants;
Postdoctoral Fellowships (PDF)
$180,000 direct costs only
($60,000 per year for up to 3 years)
Research Areas:
Basic: To expand skills and expertise in basic sciences and methods substantially advancing progress in breast cancer research and have significant potential to lead to future reductions in breast cancer incidence and/or mortality.
Translational/Clinical: To expand skill and expertise in the application of laboratory, clinical and applied disciplines to research translating laboratory, clinical and/or population discoveries into important new clinical tools and applications, with significant potential to reduce breast cancer incidence and/or mortality within the decade.
Disparities in Breast Cancer Outcomes across Population Groups: To expand understanding of the biologic, behavioral and social causes of disparities in breast cancer outcomes across population groups. Or expanding expertise in identifying, validating and testing health services and public health interventions that address the causes of disparities in care and outcomes across population groups.
Objective: PDF Grants seek to attract scientists into careers addressing important research questions about breast cancer, expand the skills and expertise of breast cancer researchers in training, and position trainees for independent careers conducting breast cancer research that will directly affect breast cancer patients.
RFA Release Date: August 30, 2011
Application system open date: August 31, 2011
Pre-Application Submission deadline: September 30, 2011
Post Baccalaureate Training in Disparities Research (PBT-DR)
$405,000 direct costs only
($45,000 per year per student; up to 3 students and up to 3 years)
PBT-DR grants are intended to establish or sustain a training program headed by a mentor(s) to provide pre-masters or pre-doctoral students with the analytic, research, scientific, clinical and/or public health skills. These skills are critical to effectively explore the basis for differences in breast cancer outcomes and translate research discoveries into clinical and public health practice. PBT-DR grants have the ultimate goal to eliminate disparities in breast cancer outcomes across population groups.
RFA Release Date: July 7, 2011
Application system open date: July 15, 2011
Komen Review Process
Susan G. Komen for the Cure® utilizes a multi-step approach to application submission and review that requires submission of a pre-application and submission of a full application upon invitation only. Pre-applications are first administratively reviewed for eligibility, adherence to formatting requirements, and responsiveness to the RFA. Qualified pre-applications are then referred to Committee to be peer reviewed by three scientists with appropriate expertise and a patient advocate reviewer. Scientist and advocate reviewers assess the strengths and weaknesses of each pre-application based on the review criteria defined in each RFA.
Only applicants with pre-applications deemed most meritorious and aligned with Komen’s research mission will be invited to submit full applications. It is anticipated that full applications will be invited from approximately 20-25% of the initial group of applications.
All institutions and industry partners must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants.
Questions? Contact the Komen Research Programs Help Desk at helpdesk@komengrantsaccess.org or toll-free 1-866-921-9678
As the global leader in the fight against breast cancer, we strive to identify the best science around the world. We are proud to currently fund research in 9 countries. Applications are welcome from investigators anywhere across the globe.
